Viking Therapeutics - Press Releases http://ir.vikingtherapeutics.com/ Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock http://ir.vikingtherapeutics.com/2018-09-20-Viking-Therapeutics-Announces-Pricing-of-175-8-Million-Public-Offering-of-Common-Stock Thu, 20 Sep 2018 20:06:00 -0400 http://ir.vikingtherapeutics.com/2018-09-20-Viking-Therapeutics-Announces-Pricing-of-175-8-Million-Public-Offering-of-Common-Stock Viking Therapeutics Announces Proposed Public Offering of Common Stock http://ir.vikingtherapeutics.com/2018-09-19-Viking-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock Wed, 19 Sep 2018 16:21:00 -0400 http://ir.vikingtherapeutics.com/2018-09-19-Viking-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol http://ir.vikingtherapeutics.com/2018-09-18-Viking-Therapeutics-Announces-Positive-Top-Line-Results-from-Phase-2-Study-of-VK2809-in-Patients-with-Non-Alcoholic-Fatty-Liver-Disease-NAFLD-and-Elevated-LDL-Cholesterol Study Achieves Primary Endpoint, Demonstrating Statistically Significant Reductions in LDL-C in Patients Receiving VK2809 Tue, 18 Sep 2018 07:05:00 -0400 http://ir.vikingtherapeutics.com/2018-09-18-Viking-Therapeutics-Announces-Positive-Top-Line-Results-from-Phase-2-Study-of-VK2809-in-Patients-with-Non-Alcoholic-Fatty-Liver-Disease-NAFLD-and-Elevated-LDL-Cholesterol Viking Therapeutics to Participate in Upcoming Investor Conferences http://ir.vikingtherapeutics.com/2018-08-28-Viking-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences Tue, 28 Aug 2018 07:30:00 -0400 http://ir.vikingtherapeutics.com/2018-08-28-Viking-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update http://ir.vikingtherapeutics.com/2018-08-09-Viking-Therapeutics-Reports-Second-Quarter-2018-Financial-Results-and-Provides-Corporate-Update Conference call scheduled for 4:30 p.m. ET today Thu, 09 Aug 2018 16:05:00 -0400 http://ir.vikingtherapeutics.com/2018-08-09-Viking-Therapeutics-Reports-Second-Quarter-2018-Financial-Results-and-Provides-Corporate-Update